Spared bone mass in rats treated with thyroid hormone receptor TRβ-selective compound GC-1

American Journal of Physiology - Endocrinology and Metabolism

Volumn 285, Issue 5 48-5, 2003, Pages

  Freitas, Fatima R S ^a   Moriscot, Anselmo S ^a   Jorgetti, Vanda ^a   Soares, Antonio G ^a   Passarelli, Marisa ^a   Scanlan, Thomas S ^b   Brent, Gregory A ^c   Bianco, Antonio C ^d   Gouveia, Cecilia H A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bone histomorphometry; Bone mineral density; Osteopenia; Osteoporosis; Thyrotoxicosis

Indexed keywords

GC 1; LIOTHYRONINE; THYROID HORMONE RECEPTOR; THYROMIMETIC AGENT; THYROTROPIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; BONE TURNOVER; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SELECTIVITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; LONG TERM CARE; LUMBAR VERTEBRA; MORPHOMETRICS; NONHUMAN; OSTEOPENIA; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; TIBIA; TRABECULAR BONE;

ANIMALS; BODY WEIGHT; BONE DENSITY; BONE DISEASES, METABOLIC; CHOLESTEROL; FEMALE; FEMUR; RATS; RATS, WISTAR; RECEPTORS, THYROID HORMONE; THYROID HORMONE RECEPTORS BETA; THYROTOXICOSIS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 0142052836     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Abu EO, Bord S, Horner A, Chatterjee VKK, and Compston JE. The expression of thyroid hormone receptors in human bone. Bone 21: 137-142, 1997.
2. Allain TJ and McGregor AM. Thyroid hormones and bone. J Endocrinol 139: 9-18, 1993.
3. Allain TJ, Thomas MR, McGregor AM, and Salisbury JR. A histomorphometric study of bone changes in thyroid dysfunction in rats. Bone 16: 505-509, 1995.
4. Amma LL, Campos-Barros A, Wang Z, Vennstrom B, and Forrest D. Distinct tissue-specific roles for thyroid hormone receptors beta and alpha1 in regulation of type 1 deiodinase expression. Mol Endocrinol 15: 467-475, 2001.
5. Ballock R, Mita BC, Zhou X, Chen DH, and Mink LM. Expression of thyroid hormone receptor isoforms in rat growth plate cartilage in vivo. J Bone Miner Res 14: 1550-1556, 1999.
6. Bianco AC, Salvatore D, Gereben B, Berry MJ, and Larsen PR. Biochemistry, cellular and molecular biology and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23: 38-89, 2002.
7. Bianco AC and Silva JE. Nuclear 3,5,3′-triiodothyronine (T3) in brown adipose tissue: receptor occupancy and sources of T3 as determined by in vivo techniques. Endocrinology 120: 55-62, 1987.
8. Chiellini G, Apriletti JW, al Yoshihara H, Baxter JD, Ribeiro RC, and Scanlan TS. A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor. Chem Biol 5: 299-306, 1998.
9. Engler H, Oettli RE, and Riesen WF. Biochemical markers of bone turnover in patients with thyroid dysfunctions and in euthyroid controls: a cross-sectional study. Clin Chim Acta 289: 159-172, 1999.
10. Forrest D, Hanebuth E, Smeyne RJ, Everds N, Stewart CL, Wehner JM, and Curran T. Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor beta: evidence for tissue-specific modulation of receptor function. EMBO J 15: 3006-3015, 1996.
11. Fox KM, Kimura S, Plato CC, and Kitagawa T. Bilateral asymmetry in bone weight at various skeletal sites of the rat. Anat Rec 241: 284-287, 1995.
12. Fraichard A, Chassande O, Plateroti M, Roux JP, Trouillas J, Dehay C, Legrand C, Gauthier K, Kedinger M, Malaval L, Rousset B, and Samarut J. The T3R alpha gene encoding a thyroid hormone receptor is essential for post-natal development and thyroid hormone production. EMBO J 16: 4412-4420, 1997.
13. Freedman LP. Anatomy of the steroid receptor zinc finger region. Endocr Rev 13: 129-145, 1992.
14. Freitas FRS, Zorn T, Labatte C, Scanlan TS, Brent GA, Moriscot AS, Bianco AC, and Gouveia CHA. Effects of the thyroid hormone receptor beta (TRb)-selective compound GC-1 on bone development of Wistar rats. Annu Mtng Am Thyroid Assoc 74th Los Angeles CA 2002, p. 125.
15. Gauthier K, Plateroti M, Harvey CB, Williams GR, Weiss RE, Refetoff S, Willott JF, Sundin V, Roux JP, Malaval L, Hara M, Samarut J, and Chassande O. Genetic analysis reveals different functions for the products of the thyroid hormone receptor alpha locus. Mol Cell Biol 21: 4748-4760, 2001.
16. Gothe S, Wang Z, Ng L, Kindblom JM, Barros AC, Ohlsson C, Vennstrom B, and Forrest D. Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev 13: 1329-1341, 1999.
17. Gouveia CH, Jorgetti V, and Bianco AC. Effects of thyroid hormone administration and estrogen deficiency on bone mass of female rats. J Bone Miner Res 12: 2098-2107, 1997.
18. Gouveia CH, Schultz JJ, Bianco AC, and Brent GA. Thyroid hormone stimulation of osteocalcin gene expression in ROS 17/2.8 cells is mediated by transcriptional and post-transcriptional mechanisms. J Endocrinol 170: 667-675, 2001.
19. Ishihara C, Kushida K, Takahashi M, Koyama S, Kawana K, Atsumi K, and Inoue T. Effect of thyroid hormone on bone and mineral metabolism in rat: evaluation by biochemical markers. Endocr Res 23: 167-180, 1997.
20. Kaneshige M, Suzuki H, Kaneshige K, Cheng J, Wimbrow H, Barlow C, Willingham MC, and Cheng S. A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfism in mice. Proc Natl Acad Sci USA 98: 15095-15100, 2001.
21. Katz D and Lazar MA. Dominant negative activity of an endogenous thyroid hormone receptor variant (alpha 2) is due to competition for binding sites on target genes. J Biol Chem 268: 20904-20910, 1993.
22. Kawaguchi H, Pilbeam CC, and Raisz LG. Anabolic effects of 3,3′,5-triiodothyronine and triiodothyroacetic acid in cultured neonatal mouse parietal bones. Endocrinology 135: 971-976, 1994.
23. Lakatos P, Foldes J, Nagy Z, Takacs I, Speer G, Horvath C, Mohan S, Baylink DJ, and Stern PH. Serum insulin-like growth factor-I, insulin-like growth factor binding proteins, and bone mineral content in hyperthyroidism. Thyroid 10: 417-423, 2000.
24. Lazar MA. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev 14: 270-279, 1993.
25. Milne M, Kang MI, Quail JM, and Baran DT. Thyroid hormone excess increases insulin-like growth factor I transcripts in bone marrow cell cultures: divergent effects on vertebral and femoral cell cultures. Endocrinology 139: 2527-2534, 1998.
26. Miura M, Tanaka K, Komatsu Y, Suda M, Yasoda A, Sakuma Y, Ozasa A, and Nakao K. A novel interaction between thyroid hormones and 1,25(OH)(2)D(3) in osteoclast formation. Biochem Biophys Res Commun 291: 987-994, 2002.
27. Miura M, Tanaka K, Komatsu Y, Suda M, Yasoda A, Sakuma Y, Ozasa A, and Nakao K. Thyroid hormones promote chondrocyte differentiation in mouse ATDC5 cells and stimulate endochondral ossification in fetal mouse tibias through iodothyronine deiodinases in the growth plate. J Bone Miner Res 17: 443-454, 2002.
28. Morte B, Manzano J, Scanlan T, Vennstrom B, and Bernal J. Deletion of the thyroid hormone receptor alpha 1 prevents the structural alterations of the cerebellum induced by hypothyroidism. Proc Natl Acad Sci USA 99: 3985-3989, 2002.
29. Mosekilde L, Eriksen EF, and Charles P. Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 19: 35-63, 1990.
30. O'Shea PJ, Harvey CB, Suzuki H, Kaneshige M, Kaneshige K, Cheng SY, and Williams GR. A thyrotoxic skeletal phenotype of advanced bone formation in mice with resistance to thyroid hormone. Mol Endocrinol 17: 1410-1424, 2003.
31. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, and Recker RR. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2: 595-610, 1987.
32. Pereira RC, Jorgetti V, and Canalis E. Triiodothyronine induces collagenase-3 and gelatinase B expression in murine osteoblasts. Am J Physiol Endocrinol Metab 277: E496-E504, 1999.
33. Recklinghausen F von. Die fibrose oder deformirende ostitis, die Osteomalacie und die osteoplastische Carcinose in ihren gegenseitigen Beziehungen. In: Rudol Virchou Festschrift, edited by Reimer G. Berlin: 1891, p. 1-89.
34. Ribeiro MO, Carvalho SD, Schultz JJ, Chiellini G, Scanlan TS, Bianco AC, and Brent GA. Thyroid hormone-sympathetic interaction and adaptive thermogenesis are thyroid hormone receptor isoform-specific. J Clin Invest 108: 97-105, 2001.
35. Suwanwalaikorn S, Ongphiphadhanakul B, Braverman LE, and Baran DT. Differential responses of femoral and vertebral bones to long-term excessive L-thyroxine administration in adult rats. Eur J Endocrinol 134: 655-659, 1996.
36. Trost SU, Swanson E, Gloss B, Wang-Iverson DB, Zhang H, Volodarsky T, Grover GJ, Baxter JD, Chiellini G, Scanlan TS, and Dillmann WH. The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity. Endocrinology 141: 3057-3064, 2000.
37. Wakasugi M, Wakao R, Tawata M, Gan N, Inoue M, Koizumi K, and Onaya T. Change in bone mineral density in patients with hyperthyroidism after attainment of euthyroidism by dual energy X-ray absorptiometry. Thyroid 4: 179-182, 1994.
38. Wikstrom L, Johansson C, Salto C, Barlow C, Campos Barros A, Baas F, Forrest D, Thoren P, and Vennstrom B. Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor alpha 1. EMBO J 17: 455-461, 1998.
39. Williams GR, Bland R, and Sheppard MC. Characterization of thyroid hormone (T3) receptors in three osteosarcoma cell lines of distinct osteoblast phenotype: interactions among T3, vitamin D3, and retinoid signaling. Endocrinology 135: 2375-2385, 1994.